Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
See Latest ArticlesDirect Economic Burden of High-Risk and Metastatic Melanoma in the Elderly: Evidence from the SEER-Medicare Linked Database
Applied Health Economics and Health Policy, 07/07/09
Davis KL et al. - The per-patient cost of advanced melanoma is high. Hospital services are the largest component of these costs. Monthly costs for subjects with stage IV melanoma were 67% higher than costs for subjects with stage IIIC disease and >3-fold higher than costs for patients with stages IIIA/B and IIB/C. However, when combining estimated monthly costs with median follow-up duration (a proxy for survival time), total costs incurred by Medicare appear to be highest for patients diagnosed at stage IIIA/B.
Related Articles
Forecasting the Future Economic Burden of Current Adolescent Overweight: An Estimate of the Coronary Heart Disease Policy Model
American Journal of Public Health, 10/28/09
Relevance Score: 67%
Hospital-based study of the severity and economic burden associated with rotavirus diarrhea in Sri Lanka
Journal of Pediatric Infectious Diseases, 11/02/09
Relevance Score: 66%
Are malaria treatment expenditures catastrophic to different socio-economic and geographic groups and how do they cope with payment? A study in southeast Nigeria
Tropical Medicine & International Health, 11/11/09
Relevance Score: 65%
The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review
Expert Opinion in Pharmacotherapy, 11/03/09
Relevance Score: 65%
Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy
Current Medical Research and Opinion, 10/30/09
Relevance Score: 65%
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
California to receive federal matching funds for electronic health record incentives program
Centers for Medicare & Medicaid Services Press, 12/18/09
Understanding the Economic Impact of a Pandemic
AMN Healthcare, 12/17/09
HHS Gets Advice on Incentive Definitions
HealthDataManagement, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor